XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders' Equity / (Deficit) - USD ($)
Total
Common Stock
Preferred Stock Member
Additional Paid-in Capital
Accumulated Deficit
Balance at Dec. 31, 2021 $ (223,876,000) $ 13,000 $ 0 $ 128,661,000 $ (352,550,000)
Balance (in Shares) at Dec. 31, 2021   132,858 0    
Stock options exercised value 96,000     96,000  
Stock options exercised (in shares)   202      
Stock-based compensation 1,355,000     1,355,000  
Net income (loss) (9,143,000)       (9,143,000)
Balance at Mar. 31, 2022 (231,568,000) $ 13,000   130,112,000 (361,693,000)
Balance (in Shares) at Mar. 31, 2022   133,060      
Stock-based compensation 1,437,000     1,437,000  
Aardvark SP-104 license transfer from Sorrento (4,127,000)     (4,127,000)  
Net income (loss) (17,838,000)       (17,838,000)
Balance at Jun. 30, 2022 (252,096,000) $ 13,000 $ 0 127,422,000 (379,531,000)
Balance (in Shares) at Jun. 30, 2022   133,060 0    
Balance at Dec. 31, 2022 36,239,000 $ 14,000 $ 3,000 412,136,000 (375,914,000)
Balance (in Shares) at Dec. 31, 2022   141,349 29,057    
Shares issued under Standby Equity Purchase Agreements, value 1,869,000     1,869,000  
Shares issued under Standby Equity Purchase Agreements   462      
Retainer shares issued 1,000 $ 1,000      
Retainer share issued (in Shares)   4,000      
Stock-based compensation 3,720,000     3,720,000  
Net income (loss) (30,753,000)       (30,753,000)
Balance at Mar. 31, 2023 11,076,000 $ 15,000 $ 3,000 417,725,000 (406,667,000)
Balance (in Shares) at Mar. 31, 2023   145,811 29,057    
Balance at Dec. 31, 2022 $ 36,239,000 $ 14,000 $ 3,000 412,136,000 (375,914,000)
Balance (in Shares) at Dec. 31, 2022   141,349 29,057    
Stock options exercised (in shares) 128        
Balance at Jun. 30, 2023 $ 10,417,000 $ 15,000 $ 3,000 443,715,000 (433,316,000)
Balance (in Shares) at Jun. 30, 2023   148,700 29,057    
Balance at Mar. 31, 2023 11,076,000 $ 15,000 $ 3,000 417,725,000 (406,667,000)
Balance (in Shares) at Mar. 31, 2023   145,811 29,057    
Shares issued under Standby Equity Purchase Agreements, value 13,925,000     13,925,000  
Shares issued under Standby Equity Purchase Agreements   2,084      
Stock options exercised value 222,000     222,000  
Stock options exercised (in shares)   128      
Stock-based compensation 3,587,000     3,587,000  
Conversion of convertible debentures into common stock, shares   632      
Conversion of convertible debentures into common stock, value 7,735,000     7,735,000  
Issuance of common stock upon warrants exercise, shares   45      
Issuance of common stock upon warrants exercise, value 521,000     521,000  
Net income (loss) (26,649,000)       (26,649,000)
Balance at Jun. 30, 2023 $ 10,417,000 $ 15,000 $ 3,000 $ 443,715,000 $ (433,316,000)
Balance (in Shares) at Jun. 30, 2023   148,700 29,057